跳至主要内容
临床试验/NCT03666234
NCT03666234Unknown不适用

Idiopathic Pulmonary Fibrosis Registry China Study

Dai Huaping1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2018年7月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
800
试验地点
1
主要终点
Demographic and clinical characteristic of newly diagnosed Chinese IPF patients

研究概览

简要总结

By mean of registry of newly diagnosed Chinese IPF patients from more than 15 sites, this study aims to build IPF prospective cohort, set up normative clinical database and a biological specimen bank, and examine the clinical characteristics of newly diagnosed Chinese IPF patients, as well as the nature history, prognosis, comorbidities and complications of IPF patients in China, the current treatment pattern, burden of illness, and quality of life of Chinese IPF patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Physician diagnosed IPF during the last 3 months based upon ATS/ERS/JRS/ALAT guidelines 2011
  • Aged 40 years and above at recruitment
  • Willing and able to sign an informed consent

排除标准

  • Inclusion in any interventional clinical trials
  • Lung transplantation expected within the next 6 months.

结局指标

主要结局

Demographic and clinical characteristic of newly diagnosed Chinese IPF patients

时间窗: up to 5 years

Data analyses will be mainly descriptive.

次要结局

  • Cause of death in Chinese patients with IPF(up to 5 years)
  • Progression-free survival in Chinese patients with IPF(up to 5 years)
  • Mortality in Chinese patients with IPF(up to 5 years)
  • Description of the acute exacerbations in Chinese patients with IPF(up to 5 years)

研究者

发起方
Dai Huaping
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dai Huaping

Deputy Director of Center for Respiratory Diseases

China-Japan Friendship Hospital

研究点 (1)

Loading locations...

相似试验